IBC Life Sciences

Asia TIDES® Scientific Advisory Committee

Bob D. Brown, Ph.D., Senior Vice President, Research, Dicerna Pharmaceuticals, USA

Jesse Dong, Ph.D., Senior Director, Medicinal Chemistry, IPSEN/Biomeasure, Incorporated, USA

Kazuko Hirabayashi, Ph.D., Principal Scientist, Pharmaceutical Information Department, Nippon Shinyaku Co., Ltd., Japan

Christopher P. Holmes, Ph.D., Executive Director, Chemistry, Affymax, Inc., USA

Yoshiaki Kiso, Ph.D., Professor & Chairman, Department of Medicinal Chemistry, Director, Center for Frontier Research in Medicinal Science, Kyoto Pharmaceutical University, Japan

David Konys, Vice President, Manufacturing Operations, Alnylam Pharmaceuticals, USA

Jesper Lau, Ph.D., Vice President, Diabetes Protein and Peptide Chemistry, Novo Nordisk, Denmark

Shawn Lee, Ph.D., President and CEO, CPC Scientific, USA and China

Ryuichi Morishita, M.D., Ph.D., Professor, Dept. of Clinical Gene Therapy, Graduate School of Medicine, Osaka University; Founder, Board Member, AnGes MG, Inc., Japan

Yoshikazu Nakamura, Ph.D., Professor, Department of Basic Medical Science, Institute of Medical Science, University of Tokyo; Founder, Ribomic, Japan

Pamela A. Pavco, Ph.D., Vice President, Pharmaceutical Development, RXi Pharmaceuticals, USA

Kal Reddy, Ph.D., Development Manager, Agilent Technologies, USA

Christopher A. Rhodes, Ph.D., Executive Director, Pharmaceutical Sciences, Amylin Pharmaceuticals, Inc., USA

Shigeki Sasaki, Ph.D., Professor, Division of Bioorganic and Synthetic Chemistry, Graduate School of Pharmaceutical Sciences, Kyushu University, Japan

Hideaki Sato, General Manager, Technical Support & Marketing Division, GeneDesign, Inc., Japan

G. Susan Srivatsa, Ph.D., President, ElixinPharma, USA

James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, Quark Pharmaceuticals, Inc., USA

Emma Wright, D.Phil., Director of Process Development, Avecia OligoMedicines, USA